METASTATIC NRG-BR004

Study #NRG-BR04

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Back To Clinical Trials NCI Database Entry